Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders

International Review of Neurobiology

Volumn 101, Issue , 2011, Pages 203-238

  Sarnyai, Zoltán ^a   Alsaif, Murtada ^a   Bahn, Sabine ^a,b   Ernst, Agnes ^a   Guest, Paul C ^a   Hradetzky, Eva ^a   Kluge, Wolfgang ^a   Stelzhammer, Viktoria ^a   Wesseling, Hendrik ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Animal models; Behavioral; Molecular; Polymorphisms; Psychiatric disorders

Indexed keywords

AMPHETAMINE; BIOLOGICAL MARKER; DONEPEZIL; DOPAMINE; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; HALOPERIDOL; LITHIUM; MOLECULAR MARKER; NEUROLEPTIC AGENT; OLANZAPINE;

ADAPTIVE BEHAVIOR; ANIMAL BEHAVIOR; BIPOLAR DISORDER; BOOK; DEVELOPMENTAL DISORDER; DISEASE MODEL; DISRUPTED IN SCHIZOPHRENIA 1 GENE; DRUG EFFECT; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GRIK2 GENE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; HUNTINGTON CHOREA; HYPOTHESIS; INTERPERSONAL COMMUNICATION; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL STRESS; METABOLIC DISORDER; MOUSE MUTANT; MUTATION RATE; NEUREGULIN 1 GENE; NEUROBIOLOGY; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; PROLINE DEHYDROGENASE GENE; PSYCHOLOGICAL MODEL; PSYCHOSIS; SCHIZOPHRENIA; TRANSLATIONAL RESEARCH;

EID: 80055091798     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387718-5.00008-0     Document Type: Chapter

References (228)

1. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13(4):355-364.
2. Ahnaou A., Nayak S., Heylen A., Ashton D., Drinkenburg W.H. Sleep and EEG profile in neonatal hippocampal lesion model of schizophrenia. Physiol. Behav. 2007, 92(3):461-467.
3. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., Ayala A.R., Licinio J., Gold H.K., Kling M.A., Chrousos G.P., Gold P.W. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J. Clin. Endocrinol. Metab. 2005, 90(5):2522-2530.
4. Ali S.F., Newport G.D., Bracha H.S. Phencyclidine and (+)-MK-801-induced circling preference: correlation with monoamine levels in striatum of the rat brain. Neurotoxicol. Teratol. 1994, 16(4):335-342.
5. Allaman I., Papp M., Kraftsik R., Fiumelli H., Magistretti P.J., Martin J.L. Expression of brain-derived neurotrophic factor is not modulated by chronic mild stress in the rat hippocampus and amygdala. Pharmacol. Rep. 2008, 60(6):1001-1007.
6. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40(7):827-834.
7. Almeida S.S., Tonkiss J., Galler J.R. Prenatal protein malnutrition affects avoidance but not escape behavior in the elevated T-maze test. Physiol. Behav. 1996, 60(1):191-195.
8. Almeida S.S., Tonkiss J., Galler J.R. Prenatal protein malnutrition affects the social interactions of juvenile rats. Physiol. Behav. 1996, 60(1):197-201.
9. Alon U., Barkai N., Notterman D.A., Gish K., Ybarra S., Mack D., Levine A.J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 1999, 96(12):6745-6750.
10. Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, American Psychiatric Press, Washington, DC. 4th edn.
11. Austin M.P., Ross M., Murray C., O'Carroll R.E., Ebmeier K.P., Goodwin G.M. Cognitive function in major depression. J. Affect. Disord. 1992, 25(1):21-29.
12. Bassett A.S., Chow E.W., Husted J., Weksberg R., Caluseriu O., Webb G.D., Gatzoulis M.A. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am. J. Med. Genet. A 2005, 138(4):307-313.
13. Baumann M.H., Rothman R.B., Ali S.F. Comparative neurobiological effects of ibogaine and MK-801 in rats. Drug Alcohol Depend. 2000, 59(2):143-151.
14. Becker A., Grecksch G. Ketamine-induced changes in rat behaviour, a possible animal model of schizophrenia. Test of predictive validity. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28(8):1267-1277.
15. Becker A., Peters B., Schroeder H., Mann T., Huether G., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27(4):687-700.
16. Becker C., Zeau B., Rivat C., Blugeot A., Hamon M., Benoliel J.J. Repeated social defeat-induced depression-like behavioral and biological alterations in rats, involvement of cholecystokinin. Mol. Psychiatry 2008, 13(12):1079-1092.
17. Belmaker R.H., Agam G. Major depressive disorder. N. Engl. J. Med. 2008, 358(1):55-68.
18. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., Smeraldi E. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 123B(1):23-26.
19. Benedict C., Frey W.H., Schioth H.B., Schultes B., Born J., Hallschmid M. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments. Exp. Gerontol. 2011, 46(2-3):112-115.
20. Beneyto M., Kristiansen L.V., Oni-Orisan A., McCullumsmith R.E., Meador-Woodruff J.H. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 2007, 32(9):1888-1902.
21. Bickel S., Lipp H.P., Umbricht D. Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function. Neuropsychopharmacology 2008, 33(7):1680-1689.
22. Bitanihirwe B.K., Weber L., Feldon J., Meyer U. Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. Int. J. Neuropsychopharmacol. 2010, 13(8):981-996.
23. Bjarnadottir M., Misner D.L., Haverfield-Gross S., Bruun S., Helgason V.G., Stefansson H., Sigmundsson A., Firth D.R., Nielsen B., Stefansdottir R., Novak T.J., Stefansson K., et al. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation, differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J. Neurosci. 2007, 27(17):4519-4529.
24. Bloomfield C., French S.J., Jones D.N., Reavill C., Southam E., Cilia J., Totterdell S. Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats. Synapse 2008, 62(8):628-631.
25. Bogerts B., Ashtari M., Degreef G., Alvir J.M., Bilder R.M., Lieberman J.A. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res. 1990, 35(1):1-13.
26. Brenes J.C., Fornaguera J. Effects of environmental enrichment and social isolation on sucrose consumption and preference, associations with depressive-like behavior and ventral striatum dopamine. Neurosci. Lett. 2008, 436(2):278-282.
27. Brown R., Colter N., Corsellis J.A., Crow T.J., Frith C.D., Jagoe R., Johnstone E.C., Marsh L. Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch. Gen. Psychiatry 1986, 43(1):36-42.
28. Brown G.W., Harris T.O., Hepworth C. Loss, humiliation and entrapment among women developing depression, a patient and non-patient comparison. Psychol. Med. 1995, 25(1):7-21.
29. Buckland P.R., Marshall R., Watkins P., McGuffin P. Does phenylethylamine have a role in schizophrenia?, LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels. Brain Res. Mol. Brain Res. 1997, 49(1-2):266-270.
30. Burke H.M., Davis M.C., Otte C., Mohr D.C. Depression and cortisol responses to psychological stress, a meta-analysis. Psychoneuroendocrinology 2005, 30(9):846-856.
31. Burt T., Sachs G.S., Demopulos C. Donepezil in treatment-resistant bipolar disorder. Biol. Psychiatry 1999, 45(8):959-964.
32. Carobrez S.G., Gasparotto O.C., Buwalda B., Bohus B. Long-term consequences of social stress on corticosterone and IL-1beta levels in endotoxin-challenged rats. Physiol. Behav. 2002, 76(1):99-105.
33. Chambers R.A., Moore J., McEvoy J.P., Levin E.D. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 1996, 15(6):587-594.
34. Clapcote S.J., Lipina T.V., Millar J.K., Mackie S., Christie S., Ogawa F., Lerch J.P., Trimble K., Uchiyama M., Sakuraba Y., Kaneda H., Shiroishi T., et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007, 54(3):387-402.
35. Cooke B.M., Chowanadisai W., Breedlove S.M. Post-weaning social isolation of male rats reduces the volume of the medial amygdala and leads to deficits in adult sexual behavior. Behav. Brain Res. 2000, 117(1-2):107-113.
36. Cotter D., Takei N., Farrell M., Sham P., Quinn P., Larkin C., Oxford J., Murray R.M., O'Callaghan E. Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus?. Schizophr. Res. 1995, 16(3):233-241.
37. Coyle J.T. Glutamate and schizophrenia, beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 2006, 26(4-6):365-384.
38. Coyle J.T. Substance use disorders and Schizophrenia: a question of shared glutamatergic mechanisms. Neurotox. Res. 2006, 10:221-233.
39. Dagyte G., Crescente I., Postema F., Seguin L., Gabriel C., Mocaer E., Boer J.A., Koolhaas J.M. Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress. Behav. Brain Res. 2011, 218(1):121-128.
40. Day-Wilson K.M., Jones D.N., Southam E., Cilia J., Totterdell S. Medial prefrontal cortex volume loss in rats with isolation rearing-induced deficits in prepulse inhibition of acoustic startle. Neuroscience 2006, 141(3):1113-1121.
41. Deakin I.H., Law A.J., Oliver P.L., Schwab M.H., Nave K.A., Harrison P.J., Bannerman D.M. Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 2009, 20(17):1523-1528.
42. Deng C., Weston-Green K.L., Han M., Huang X.F. Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31(4):915-920.
43. Detanico B.C., Piato A.L., Freitas J.J., Lhullier F.L., Hidalgo M.P., Caumo W., Elisabetsky E. Antidepressant-like effects of melatonin in the mouse chronic mild stress model. Eur. J. Pharmacol. 2009, 607(1-3):121-125.
44. Duffy L., Cappas E., Scimone A., Schofield P.R., Karl T. Behavioral profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. Behav. Neurosci. 2008, 122(4):748-759.
45. Duffy L., Cappas E., Lai D., Boucher A.A., Karl T. Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 2010, 170(3):800-807.
46. Duncko R., Kiss A., Skultetyova I., Rusnak M., Jezova D. Corticotropin-releasing hormone mRNA levels in response to chronic mild stress rise in male but not in female rats while tyrosine hydroxylase mRNA levels decrease in both sexes. Psychoneuroendocrinology 2001, 26(1):77-89.
47. Dzirasa K., Santos L.M., Ribeiro S., Stapleton J., Gainetdinov R.R., Caron M.G., Nicolelis M.A. Persistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleep. PLoS One 2009, 4(4):e5238.
48. Easton A., Arbuzova J., Turek F.W. The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav. 2003, 2:11-19.
49. Egerton A., Reid L., McGregor S., Cochran S.M., Morris B.J., Pratt J.A. Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology (Berl.) 2008, 198(1):37-49.
50. Ehrlichman R.S., Luminais S.N., White S.L., Rudnick N.D., Ma N., Dow H.C., Kreibich A.S., Abel T., Brodkin E.S., Hahn C.G., Siegel S.J. Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions. Brain Res. 2009, 1294:116-127.
51. English J.A., Pennington K., Dunn M.J., Cotter D.R. The neuroproteomics of schizophrenia. Biol. Psychiatry 2011, 69(2):163-172.
52. Enomoto T., Floresco S.B. Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(4):668-675.
53. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., Shier A., Sheikh S., Bailey K. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol. Psychiatry 1999, 4(2):145-154.
54. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., Shi L., Sidwell R. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood, implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol. 2002, 22(1):25-33.
55. Flagstad P., Mork A., Glenthoj B.Y., van Beek J., Michael-Titus A.T., Didriksen M. Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsychopharmacology 2004, 29(11):2052-2064.
56. Flagstad P., Glenthoj B.Y., Didriksen M. Cognitive deficits caused by late gestational disruption of neurogenesis in rats, a preclinical model of schizophrenia. Neuropsychopharmacology 2005, 30(2):250-260.
57. Fone K.C., Porkess M.V. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neurosci. Biobehav. Rev. 2008, 32(6):1087-1102.
58. Fortier M.E., Joober R., Luheshi G.N., Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J. Psychiatr. Res. 2004, 38(3):335-345.
59. Francis D., Diorio J., LaPlante P., Weaver S., Seckl J.R., Meaney M.J. The role of early environmental events in regulating neuroendocrine development. Moms, pups, stress, and glucocorticoid receptors. Ann. N. Y. Acad. Sci. 1996, 794:136-152.
60. Frey B.N., Valvassori S.S., Gomes K.M., Martins M.R., Dal-Pizzol F., Kapczinski F., et al. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 2006, 1097(1):224-229.
61. Frodl T.S., Koutsouleris N., Bottlender R., Born C., Jager M., Scupin I., Reiser M., Moller H.J., Meisenzahl E.M. Depression-related variation in brain morphology over 3years, effects of stress?. Arch. Gen. Psychiatry 2008, 65(10):1156-1165.
62. Fury W., Batliwalla F., Gregersen P.K., Li W. Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2006, 1:5531-5534.
63. Gainetdinov R.R., Jones S.R., Fumagalli F., Wightman R.M., Caron M.G. Re-evaluation of the role of the dopamine transporter in dopamine system homeostatsis. Brain Res. Brain Res. Rev. 1998, 26:148-153.
64. Gainetdinov R.R., Jones S.R., Caron M.G. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol. Psychiatry 1999, 46(3):303-311. Review.
65. Gerlai R., Pisacane P., Erickson S. Heregulin, but not ErbB2 or ErbB3 heterozygous mutant mice exhibit hyperactivity in multiple behavioural tasks. Behav. Brain Res. 2000, 109(2):219.
66. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia, a decade in review. Psychopharmacology (Berl.) 2001, 156(2-3):117-154.
67. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379(6566):606-612.
68. Gogos J.A., Satha M., Takacs Z., Beck K.D., Luine V., Lucas L.R., Nadler J.V., Karayiorgou M. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 1999, 21:434-439.
69. Goto Y., Grace A.A. Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development. Biol. Psychiatry 2006, 60(11):1259-1267.
70. Grande I., Fries G., Kunz M., Kapczinski F. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig. 2010, 7(4):243-250.
71. Greenstein R., Novak G., Seeman P. Amphetamine sensitization elevates CaMKIIbeta mRNA. Synapse 2007, 61(10):827-834.
72. Gresack J.E., Risbrough V.B., Scott C.N., Coste S., Stenzel-Poore M., Geyer M.A., Powell S.B. Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behav. Brain Res. 2010, 209(1):80-84.
73. Grippo A.J., Francis J., Beltz T.G., Felder R.B., Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol. Behav. 2005, 84(5):697-706.
74. Halene T.B., Ehrlichman R.S., Liang Y., Christian E.P., Jonak G.J., Gur T.L., Blendy J.A., Dow H.C., Brodkin E.S., Schneider F., Gur R.C., Siegel S.J. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav. 2009, 8(7):661-675.
75. Hall F.S., Li X.F., Randall-Thompson J., Sora I., Murphy D.L., Lesch K.P., Caron M., Uhl G.R. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 2009, 162(4):870-880.
76. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999, 122(Pt. 4):593-624.
77. Heidbreder C.A., Weiss I.C., Domeney A.M., Pryce C., Homberg J., Hedou G., Feldon J., Moran M.C., Nelson P. Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome. Neuroscience 2000, 100(4):749-768.
78. Henningsen K., Andreasen J.T., Bouzinova E.V., Jayatissa M.N., Jensen M.S., Redrobe J.P., Wiborg O. Cognitive deficits in the rat chronic mild stress model for depression, relation to anhedonic-like responses. Behav. Brain Res. 2009, 198(1):136-141.
79. Hikida T., Jaaro-Peled H., Seshadri S., Oishi K., Hookway C., Kong S., Wu D., Xue R., Andradé M., Tankou S., Mori S., Gallagher M., et al. Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl. Acad. Sci. USA 2007, 104(36):14501-14506.
80. Howes O.D., Kapur S. The dopamine hypothesis of schizophrenia, version III-the final common pathway. Schizophr. Bull. 2009, 35(3):549-562.
81. Hradetzky, E., Sanderson, T.M., Tsang, T.M., Lakics, V., Malik, N., O'Neill, M.C., Schoeffmann, S., Cheng, T., Harris, L.W., Guest, P.C., Rahmoune, H., Holmes, E., Tricklebank, M., and Bahn, S. Methylazoxymethanol acetate rat model, molecular and functional altered synaptic transmission in the hippocampus. (submitted).
82. Hsu L.L., Smith R.C., Rolsten C., Leelavathi D.E. Effects of acute and chronic phencyclidine on neurotransmitter enzymes in rat brain. Biochem. Pharmacol. 1980, 29(18):2524-2526.
83. Hwu H.G., Liu C.M., Fann C.S., Ou-Yang W.C., Lee S.F. Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. Mol. Psychiatry 2003, 8:445-452.
84. Ikonomov O.C., Manji H.K. Molecular mechanisms underlying mood stabilization in manic-depressive illness, the phenotype challenge. Am. J. Psychiatry 1999, 156(10):1506-1514.
85. Insel T., Cuthbert B., Garvey M., Heinssen R., Pine D.S., Quinn K., Sanislow C., Wang P. Research domain criteria (RDoC), toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167(7):748-751.
86. Javitt D.C. Glutamate and schizophrenia, phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 2007, 78:69-108.
87. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148(10):1301-1308.
88. Jayatissa M.N., Henningsen K., Nikolajsen G., West M.J., Wiborg O. A reduced number of hippocampal granule cells does not associate with an anhedonia-like phenotype in a rat chronic mild stress model of depression. Stress 2010, 13(2):95-105.
89. Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 1997, 17(2):92-99.
90. Jiménez-Marín Á., Collado-Romero M., Ramirez-Boo M., Arce C., Garrido J.J. Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis. BMC Proc. 2009, 3(Suppl. 4):S6.
91. Kabbaj M., Norton C.S., Kollack-Walker S., Watson S.J., Robinson T.E., Akil H. Social defeat alters the acquisition of cocaine self-administration in rats, role of individual differences in cocaine-taking behavior. Psychopharmacology (Berl.) 2001, 158(4):382-387.
92. Kaddurah-Daouk R., McEvoy J., Baillie R.A., Lee D., Yao J.K., Doraiswamy P.M., et al. Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol. Psychiatry 2007, 12(10):934-945.
93. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. USA 1995, 92(17):7612-7616.
94. Karayiorgou M., Simon T.J., Gogos J.A. 22q11.2 microdeletions, linking DNA structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci. 2010, 11(6):402-416.
95. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 2005, 136(1-2):29-37.
96. Kavelaars A., Cobelens P.M., Teunis M.A., Heijnen C.J. Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene. J. Neuroimmunol. 2005, 161(1-2):162-168.
97. Keilhoff G., Becker A., Grecksch G., Wolf G., Bernstein H.G. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 2004, 126(3):591-598.
98. Keilhoff G., Bernstein H.G., Becker A., Grecksch G., Wolf G. Increased neurogenesis in a rat ketamine model of schizophrenia. Biol. Psychiatry 2004, 56(5):317-322.
99. Kimber W.L., Hsieh P., Hirotsune S., Yuva-Paylor L., Sutherland H.F., Chen A., Ruiz-Lozano P., Hoogstraten-Miller S.L., Chien K.R., Paylor R., Scambler P.J., Wynshaw-Boris A. Deletion of 150kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. Hum. Mol. Genet. 1999, 8(12):2229-2237.
100. Koike H., Arguello P.A., Kvajo M., Karayiorgou M., Gogos J.A. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. USA 2006, 103(10):3693-3697.
101. Kondziella D., Brenner E., Eyjolfsson E.M., Markinhuhta K.R., Carlsson M.L., Sonnewald U. Glial-neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure. Neuropsychopharmacology 2006, 31(9):1880-1887.
102. Korotkova T., Fuchs E.C., Ponomarenko A., von Engelhardt J., Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68(3):557-569.
103. Kovanen L., Saarikoski S., Aromaa A., Lönnqvist J., Partonen T. ARNTL (BMAL1) and NPAS2 gene variants contribute to fertility and seasonality. PLoS One 2010, 5(4):e10007.
104. Kvajo M., McKellar H., Arguello P.A., Drew L.J., Moore H., MacDermott A.B., Karayiorgou M., Gogos J.A. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proc. Natl. Acad. Sci. USA 2008, 105(19):7076-7081.
105. Ladd C.O., Huot R.L., Thrivikraman K.V., Nemeroff C.B., Meaney M.J., Plotsky P.M. Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog. Brain Res. 2000, 122:81-103.
106. Laron Z. Insulin and the brain. Arch. Physiol. Biochem. 2009, 115(2):112-116.
107. Le Pen G., Moreau J.L. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia, reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 2002, 27(1):1-11.
108. Le Pen G., Gourevitch R., Hazane F., Hoareau C., Jay T.M., Krebs M.O. Peri-pubertal maturation after developmental disturbance, a model for psychosis onset in the rat. Neuroscience 2006, 143(2):395-405.
109. Lepsch L.B., Gonzalo L.A., Magro F.J., Delucia R., Scavone C., Planeta C.S. Exposure to chronic stress increases the locomotor response to cocaine and the basal levels of corticosterone in adolescent rats. Addict. Biol. 2005, 10(3):251-256.
110. Levin Y., Wang L., Schwarz E., Koethe D., Leweke F.M., Bahn S. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum. Mol. Psychiatry 2010, 15(11):1088-1100.
111. Li Q., Cheung C., Wei R., Hui E.S., Feldon J., Meyer U., Chung S., Chua S.E., Sham P.C., Wu E.X., McAlonan G.M. Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia, evidence from MRI in a mouse model. PLoS One 2009, 4(7):e6354.
112. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage, a potential animal model of schizophrenia. Neuropsychopharmacology 1993, 9(1):67-75.
113. Lipska B.K., Chrapusta S.J., Egan M.F., Weinberger D.R. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse 1995, 20(2):125-130.
114. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl.) 1995, 122(1):35-43.
115. Lodge D.J., Lawrence A.J. The effect of isolation rearing on volitional ethanol consumption and central CCK/dopamine systems in Fawn-Hooded rats. Behav. Brain Res. 2003, 141(2):113-122.
116. Long J.M., LaPorte P., Merscher S., Funke B., Saint-Jore B., Puech A., Kucherlapati R., Morrow B.E., Skoultchi A.I., Wynshaw-Boris A. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 2006, 7(4):247-257.
117. Lu Y., Huggins P., Bar-Joseph Z. Cross species analysis of microarray expression data. Bioinformatics 2009, 25(12):1476-1483.
118. Ma D., Chan M.K., Lockstone H.E., Pietsch S.R., Jones D.N., Cilia J., et al. Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortex. J. Proteome Res. 2009, 8(7):3284-3297.
119. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmias C., Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl. Acad. Sci. USA 2003, 100(3):1387-1392.
120. Marichich E.S., Molina V.A., Orsingher O.A. Persistent changes in central catecholaminergic system after recovery of perinatally undernourished rats. J. Nutr. 1979, 109(6):1045-1050.
121. Marini F., Pozzato C., Andreetta V., Jansson B., Arban R., Domenici E., Carboni L. Single exposure to social defeat increases corticotropin-releasing factor and glucocorticoid receptor mRNA expression in rat hippocampus. Brain Res. 2006, 1067(1):25-35.
122. Markianos M., Panas M., Kalfakis N., Hatzimanolis J., Vassilopoulos D. Neuroendocrine evidence of normal hypothalamus-pituitary dopaminergic function in Huntington's disease. Neuro Endocrinol. Lett. 2010, 31(3):359-362.
123. Marmol F. Lithium, bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(8):1761-1771.
124. Martins-de-Souza D., Harris L.W., Guest P.C., Bahn S. The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid. Redox Signal. 2010, Dec 2. (Epub ahead of print).
125. McArthur R., Borsini F. Animal models of depression in drug discovery, a historical perspective. Pharmacol. Biochem. Behav. 2006, 84(3):436-452.
126. McClung C.A., Sidiropoulou K., Vitaterna M., Takahashi J.S., White F.J., Cooper D.C., Nestler E.J. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc. Natl. Acad. Sci. USA 2005, 102(26):9377-9381.
127. McGuire J., Herman J.P., Horn P.S., Sallee F.R., Sah R. Enhanced fear recall and emotional arousal in rats recovering from chronic variable stress. Physiol. Behav. 2010, 101(4):474-482.
128. McLachlan G.J., Bean R.W., Peel D. A mixture model-based approach to the clustering of microarray expression data. Bioinformatics 2002, 18(3):413-422.
129. McLoughlin G.A., Ma D., Tsang T.M., Jones D.N., Cilia J., Hill M.D., et al. Analyzing the effects of psychotropic drugs on metabolite profiles in rat brain using 1H NMR spectroscopy. J. Proteome Res. 2009, 8(4):1943-1952.
130. McQueen M.B., Devlin B., Faraone S.V., Nimgaonkar V.L., Sklar P., Smoller J.W., Abou Jamra R., Albus M., Bacanu S.-A., Baron M., Barrett T.B., Berrettini W., et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am. J. Hum. Genet. 2005, 77(4):582-595.
131. Meaney M.J. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 2001, 24:1161-1192.
132. Meechan D.W., Tucker E.S., Maynard T.M., LaMantia A.S. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome. Proc. Natl. Acad. Sci. USA 2009, 106(38):16434-16445.
133. Meerlo P., de Bruin E.A., Strijkstra A.M., Daan S. A social conflict increases EEG slow-wave activity during subsequent sleep. Physiol. Behav. 2001, 73(3):331-335.
134. Meltzer H.Y., Stahl S.M. The dopamine hypothesis of schizophrenia, a review. Schizophr. Bull. 1976, 2(1):19-76.
135. Meng Q., Li N., Han X., Shao F., Wang W. Effects of adolescent social isolation on the expression of brain-derived neurotrophic factors in the forebrain. Eur. J. Pharmacol. 2011, 650(1):229-232.
136. Meunier B., Dumas E., Piec I., Béchet D., Hébraud M., Hocquette J. Assessment of hierarchical clustering methodologies for proteomic data mining. J. Proteome Res. 2007, 6(1):358-366.
137. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90(3):285-326.
138. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 2008, 33(2):441-456.
139. Michailov G.V., Sereda M.W., Brinkmann B.G., Fischer T.M., Haug B., Birchmeier C., Role L., Lai C., Schwab M.H., Nave K.A. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004, 304:700-703.
140. Mikova O., Yakimova R., Bosmans E., Kenis G., Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur. Neuropsychopharmacol. 2001, 11(3):203-208.
141. Mineur Y.S., Belzung C., Crusio W.E. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice. Behav. Brain Res. 2006, 175(1):43-50.
142. Miyamoto S., Leipzig J.N., Lieberman J.A., Duncan G.E. Effects of ketamine, MK-801, and amphetamine on regional brain 2-deoxyglucose uptake in freely moving mice. Neuropsychopharmacology 2000, 22(4):400-412.
143. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine, a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 1997, 17(8):2921-2927.
144. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98(4):427-436.
145. Moore H., Jentsch J.D., Ghajarnia M., Geyer M.A., Grace A.A. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17, implications for the neuropathology of schizophrenia. Biol. Psychiatry 2006, 60(3):253-264.
146. Moy S.S., Perez A., Koller B.H., Duncan G.E. Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res. 2006, 1089(1):186-194.
147. Mukai J., Dhilla A., Drew L.J., Stark K.L., Cao L., MacDermott A.B., Karayiorgou M., Gogos J.A. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 2008, 11(11):1302-1310.
148. Müller-Oerlinghausen B., Berghöfer A., Bauer M. Bipolar disorder. Lancet 2002, 359(9302):241-247.
149. Nabeshima T., Hiramatsu M., Furukawa H., Kameyama T. Effects of acute and chronic administrations of phencyclidine on the levels of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of mouse. Life Sci. 1985, 36(10):939-946.
150. Nabeshima T., Kozawa T., Furukawa H., Kameyama T. Phencyclidine-induced retrograde amnesia in mice. Psychopharmacology (Berl.) 1986, 89(3):334-337.
151. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13(10):1161-1169.
152. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34(1):13-25.
153. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A., Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse 1996, 22(4):304-312.
154. Noda A., Noda Y., Kamei H., Ichihara K., Mamiya T., Nagai T., et al. Phencyclidine impairs latent learning in mice, interaction between glutamatergic systems and sigma(1) receptors. Neuropsychopharmacology 2001, 24(4):451-460.
155. O'Brien S.M., Scully P., Scott L.V., Dinan T.G. Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients. J. Affect. Disord. 2006, 90(2-3):263-267.
156. O'Tuathaigh C.M., Babovic D., O'Sullivan G.J., Clifford J.J., Tighe O., Croke D.T., Harvey R., Waddington J.L. Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 2007, 147(1):18-27.
157. O'Tuathaigh C.M., O'Connor A.M., O'Sullivan G.J., Lai D., Harvey R., Croke D.T., Waddington J.L. Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(2):462-466.
158. Orzi F., Dow-Edwards D., Jehle J., Kennedy C., Sokoloff L. Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat. J. Cereb. Blood Flow Metab. 1983, 3(2):154-160.
159. Palmer A.A., Printz D.J., Butler P.D., Dulawa S.C., Printz M.P. Prenatal protein deprivation in rats induces changes in prepulse inhibition and NMDA receptor binding. Brain Res. 2004, 996(2):193-201.
160. Palmer A.A., Brown A.S., Keegan D., Siska L.D., Susser E., Rotrosen J., Butler P.D. Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding. Brain Res. 2008, 1237:62-74.
161. Paule M.G. Acute behavioral toxicity of MK-801 and phencyclidine, effects on rhesus monkey performance in an operant test battery. Psychopharmacol. Bull. 1994, 30(4):613-621.
162. Paylor R., McIlwain K.L., McAninch R., Nellis A., Yuva-Paylor L.A., Baldini A., Lindsay E.A. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum. Mol. Genet. 2001, 10(23):2645-2650.
163. Pechnick R.N., George R., Poland R.E., Hiramatsu M., Cho A.K. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat, evidence for the differential development of tolerance. J. Pharmacol. Exp. Ther. 1989, 250(2):534-540.
164. Pellerin L. Lactate as a pivotal element in neuron-glia metabolic cooperation. Neurochem. Int. 2003, 43(4-5):331-338.
165. Perona M.T., Waters S., Hall F.S., Sora I., Lesch K.P., Murphy D.L., Caron M., Uhl G.R. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice, prominent effects of dopamine transporter deletions. Behav. Pharmacol. 2008, 19(5-6):566-574.
166. Pizarro J.M., Lumley L.A., Medina W., Robison C.L., Chang W.E., Alagappan A., Bah M.J., Dawood M.Y., Shah J.D., Mark B., Kendall N., Smith M.A., et al. Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res. 2004, 1025(1-2):10-20.
167. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., Mori S., Moran T.H., Ross C.A. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry 2008, 13(2):173-186. 115.
168. Pogorelov V.M., Rodriguiz R.M., Insco M.L., Caron M.G., Wetsel W.C. Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 2005, 30(10):1818-1831.
169. Pogorelov V.M., Nomura J., Kim J., Kannan G., Ayhan Y., Yang C., Taniguchi Y., Abazyan B., Valentine H., Krasnova I.N., Kamiya A., Cadet J.L., et al. Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference, a comorbidity model. Neuropharmacology 2011, Feb 17. (Epub ahead of print).
170. Powell N.D., Bailey M.T., Mays J.W., Stiner-Jones L.M., Hanke M.L., Padgett D.A., Sheridan J.F. Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion. Brain Behav. Immun. 2009, 23(2):225-231.
171. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., Steckler T. Transgenic mice overexpressing glycogen synthase kinase 3 beta, A putative model of hyperactivity and mania. J. Neurosci. 2006, 26(35):9022-9029.
172. Pugh C.R., Nguyen K.T., Gonyea J.L., Fleshner M., Wakins L.R., Maier S.F., Rudy J.W. Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behav. Brain Res. 1999, 106(1-2):109-118.
173. Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 2000, 48(8):766-777.
174. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.A. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice, differential effects of D1 and D2 receptor antagonists. J. Neurosci. 2001, 21(1):305-313.
175. Ramsey A.J., Laakso A., Cyr M., Sotnikova T.D., Salahpour A., Medvedev I.O., Dykstra L.A., Gainetdinov R.R., Caron M.G. Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. Neuropsychopharmacology 2008, 33(11):2701-2714.
176. Reddy A.B., Karp N.A., Maywood E.S., Sage E.A., Deery M., O'Neill J.S., Wong G.K.Y., Chesham J., Odell M., Lilley K.S., Kyriacou C.P., Hastings M.H. Circadian orchestration of the hepatic proteome. Curr. Biol. 2006, 16:1107-1115.
177. Rimer M., Barrett D.W., Maldonado M.A., Vock V.M., Gonzalez-Lima F. Neuregulin-1 immunoglobulin-like domain mutant mice, clozapine sensitivity and impaired latent inhibition. Neuroreport 2005, 16(3):271-275.
178. Rodriguiz R.M., Chu R., Caron M.G., Wetsel W.C. Aberrant responses in social interaction of dopamine transporter knockout mice. Behav. Brain Res. 2004, 148(1-2):185-198.
179. Romero E., Guaza C., Castellano B., Borrell J. Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats, implications for the etiopathology of schizophrenia. Mol. Psychiatry 2010, 15(4):372-383.
180. Roybal K., Theobold D., Graham A., DiNieri J.A., Russo S.J., Krishnan V., Chakravarty S., Peevey J., Oehrlein N., Birnbaum S., Vitaterna M.H., Orsulak P., et al. Mania-like behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. USA 2007, 104(15):6406-6411.
181. Rygula R., Abumaria N., Flugge G., Fuchs E., Ruther E., Havemann-Reinecke U. Anhedonia and motivational deficits in rats, impact of chronic social stress. Behav. Brain Res. 2005, 162(1):127-134.
182. Salvadore G., Quiroz J., Machado-Vieira R., Henter I.D., Manji H.K., Zarate C.A. The neurobiology of the switch process in bipolar disorder, a review. J. Clin. Psychiatry 2010, 71(11):1488-1501.
183. Sampaio A.S., Fagerness J., Crane J., Leboyer M., Delorme R., Pauls D.L., Stewart S.E. Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder, a family-based study. CNS Neurosci. Ther. 2010, 17:141-147.
184. Sams-Dodd F. Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats. Behav. Pharmacol. 1995, 6(1):55-65.
185. Sams-Dodd F., Lipska B.K., Weinberger D.R. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl.) 1997, 132(3):303-310.
186. Sanberg P.R., Pevsner J., Autuono P.G., Coyle J.T. Fetal methylazoxymethanol acetate-induced lesions cause reductions in dopamine receptor-mediated catalepsy and stereotypy. Neuropharmacology 1985, 24(11):1057-1062.
187. Sandstrom N.J., Hart S.R. Isolation stress during the third postnatal week alters radial arm maze performance and corticosterone levels in adulthood. Behav. Brain Res. 2005, 156(2):289-296.
188. Sarnyai Z., Shaham Y., Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 2001, 53(2):209-243.
189. Sei H., Sano A., Oishi K., Fujihara H., Kobayashi H., Ishida N., Morita Y. Increase of hippocampal acetylcholine release at the onset of dark phase is suppressed in a mutant mice model of evening-type individuals. Neuroscience 2003, 117(4):785-789.
190. Seillier A., Giuffrida A. Evaluation of NMDA receptor models of schizophrenia, divergences in the behavioral effects of sub-chronic PCP and MK-801. Behav. Brain Res. 2009, 204(2):410-415.
191. Shaltiel G., Chen G., Manji H.K. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr. Opin. Pharmacol. 2007, 7(1):22-26.
192. Shaltiel G., Maeng S., Malkesman O., Pearson B., Schloesser R.J., Tragon T., Rogawski M., Gasior M., Luckenbaugh D., Chen G., Manji H.K. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol. Psychiatry 2008, 13(9):858-872.
193. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23(1):297-302.
194. Silva-Gomez A.B., Rojas D., Juarez I., Flores G. Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res. 2003, 983(1-2):128-136.
195. Song L., Che W., Min-Wei W., Murakami Y., Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol. Biochem. Behav. 2006, 83(2):186-193.
196. Spielewoy C., Roubert C., Hamon M., Nosten-Bertrand M., Betancur C., Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav. Pharmacol. 2000, 11(3-4):279-290.
197. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., Evans H.J. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336(8706):13-16.
198. Stark K.L., Xu B., Bagchi A., Lai W.S., Liu H., Hsu R., Wan X., Pavlidis P., Mills A.A., Karayiorgou M., Gogos J.A. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat. Genet. 2008, 40(6):751-760.
199. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., Hjaltason O., Birgisdottir B., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
200. Steiger J.L., Alexander M.J., Galler J.R., Farb D.H., Russek S.J. Effects of prenatal malnutrition on GABAA receptor alpha1, alpha3 and beta2 mRNA levels. Neuroreport 2003, 14(13):1731-1735.
201. Stine C.D., Lu W., Wolf M.E. Expression of AMPA receptor flip and flop mRNAs in the nucleus accumbens and prefrontal cortex after neonatal ventral hippocampal lesions. Neuropsychopharmacology 2001, 24(3):253-266.
202. Strutz-Seebohm N., Korniychuk G., Schwarz R., Baltaev R., Ureche O.N., Mack A.F., Ma Z.L., Hollmann M., Lang F., Seebohm G. Functional significance of the kainate receptor GluR6(M836I) mutation that is linked to autism. Cell. Physiol. Biochem. 2006, 18(4-5):287-294.
203. Sturgeon R.D., Fessler R.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur. J. Pharmacol. 1979, 59(3-4):169-179.
204. Tamminga C.A., Tanimoto K., Kuo S., Chase T.N., Contreras P.C., Rice K.C., et al. PCP-induced alterations in cerebral glucose utilization in rat brain, blockade by metaphit, a PCP-receptor-acylating agent. Synapse 1987, 1(5):497-504.
205. Tenn C.C., Kapur S., Fletcher P.J. Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology (Berl.) 2005, 180(2):366-376.
206. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1beta in late-life depression. Am. J. Psychiatry 2005, 162(1):175-177.
207. Tonkiss J., Galler J.R. Prenatal protein malnutrition and working memory performance in adult rats. Behav. Brain Res. 1990, 40(2):95-107.
208. Toth M., Mikics E., Tulogdi A., Aliczki M., Haller J. Post-weaning social isolation induces abnormal forms of aggression in conjunction with increased glucocorticoid and autonomic stress responses. Horm. Behav. 2011, 60:28-36.
209. Tseng K.Y., Lewis B.L., Hashimoto T., Sesack S.R., Kloc M., Lewis D.A., O'Donnell P. A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J. Neurosci. 2008, 28(48):12691-12699.
210. Uehara T., Sumiyoshi T., Seo T., Matsuoka T., Itoh H., Suzuki M., et al. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats. Brain Res. 2010, 1352:223-230.
211. Usiskin S.I., Nicolson R., Krasnewich D.M., Yan W., Lenane M., Wudarsky M., Hamburger S.D., Rapoport J.L. Velocardiofacial syndrome in childhood-onset schizophrenia. J. Am. Acad. Child Adolesc. Psychiatry 1999, 38(12):1536-1543.
212. van den Buuse M., Wischhof L., Lee R.X., Martin S., Karl T. Neuregulin 1 hypomorphic mutant mice, enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation. Int. J. Neuropsychopharmacol. 2009, 12(10):1383-1393.
213. Vaynman S., Ying Z., Wu A., Gomez-Pinilla F. Coupling energy metabolism with a mechanism to support brain-derived neurotrophic factor-mediated synaptic plasticity. Neuroscience 2006, 139(4):1221-1234.
214. Vidal J., Bie J., Granneman R.A., Wallinga A.E., Koolhaas J.M., Buwalda B. Social stress during adolescence in Wistar rats induces social anxiety in adulthood without affecting brain monoaminergic content and activity. Physiol. Behav. 2007, 92(5):824-830.
215. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F., Babler A., Vogel H., Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 1998, 9(17):3897-3902.
216. Wang X.D., Su Y.A., Guo C.M., Yang Y., Si T.M. Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. Int. J. Neuropsychopharmacol. 2008, 11(4):553-561.
217. Wang M., Pei L., Fletcher P.J., Kapur S., Seeman P., Liu F. Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration, increased dopamine D2 receptor dimerization. Mol. Brain 2010, 3:25.
218. Watt M.J., Burke A.R., Renner K.J., Forster G.L. Adolescent male rats exposed to social defeat exhibit altered anxiety behavior and limbic monoamines as adults. Behav. Neurosci. 2009, 123(3):564-576.
219. Wiley J.L., Porter J.H., Compton A.D., Balster R.L. Antipunishment effects of acute and repeated administration of phencyclidine and NPC 12626 in rats. Life Sci. 1992, 50(20):1519-1528.
220. Willner P. Validity, reliability and utility of the chronic mild stress model of depression, a 10-year review and evaluation. Psychopharmacology (Berl.) 1997, 134(4):319-329.
221. Woodin M., Wang P.P., Aleman D., McDonald-McGinn D., Zackai E., Moss E. Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet. Med. 2001, 3(1):34-39.
222. The global burden of disease, 2004 update 2004, World Health Organisation, World health Organization Publication, Geneva.
223. Wu W., Yamaura T., Murakami K., Ogasawara M., Hayashi K., Murata J., Saiki I. Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress. Oncol. Res. 1999, 11(10):461-469.
224. Yamaguchi K., Nabeshima T., Ishikawa K., Yoshida S., Kameyama T. Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats. Neuropharmacology 1987, 26(10):1489-1497.
225. Yanik M., Vural H., Tutkun H., Zoroĝlu S., Savaş H., Herken H., Koçyiĝit A., Keleş H., Akyol Ö. The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254(1):43-47.
226. Young J.W., Powell S.B., Risbrough V., Marston H.M., Geyer M.A. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol. Ther. 2009, 122(2):150-202.
227. Yu T., Guo M., Garza J., Rendon S., Sun X.L., Zhang W., Lu X.Y. Cognitive and neural correlates of depression-like behaviour in socially defeated mice, an animal model of depression with cognitive dysfunction. Int. J. Neuropsychopharmacol. 2011, 14(3):303-317.
228. Zuo D.Y., Zhang Y.H., Cao Y., Wu C.F., Tanaka M., Wu Y.L. Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior. Life Sci. 2006, 78(19):2172-2178.